COVID-19 Variant JN.1 is on the Rise. Here’s What to Know.
December 20, 2023
The new JN.1 COVID-19 variant is now estimated to make up about 20% of cases in the United States. Three UCSF experts offer advice on vaccines, masking, and other ways to protect yourself. U.S. Men Die 6 Years Before Women, as Life Expectancy Gap Widens
November 13, 2023
New research shows that in the U.S., the longevity gap between women and men has been widening for more than a decade, with women outliving men by an average of six years. Shared Mechanisms Allow SARS-CoV-2 Variants to Thrive Post-Vaccination
September 21, 2023
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers. New COVID-19 Vaccines: Is it Worth the Shot?
September 20, 2023
Recommendations are in place for the updated COVID-19 vaccine from Pfizer-BioNTech and Moderna. Protect Yourself and Loved Ones with the New RSV Vaccines
September 14, 2023
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults. Long COVID Symptoms Can Emerge Months After Infection
August 10, 2023
Long COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing. Gene Mutation May Explain Why Some Don’t Get Sick from COVID-19
July 19, 2023
A common mutation can help people infected with the COVID-19 virus avoid developing any symptoms. COVID-19 Vaccines Saved Dementia Patients’ Lives in Nursing Homes
July 17, 2023
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home. COVID-19 Lessons Learned: ‘Why Aren’t We Working on All Diseases Like This?’
June 14, 2023
Quantitative Biosciences Institute’s Nevan Krogan reflects back on the COVID-19 pandemic and how internal and external communications, funding and international partnerships all contributed to a speedy COVID-19 response. Does Your Vaccine Type Matter in the Battle Against COVID?
May 09, 2023
COVID vaccine efficacy varied by age, BMI, sex, and smoking status, with levels changing over six months in a UCSF-led study. Pfizer and Moderna had higher antibody responses than Johnson & Johnson at one month, but Johnson & Johnson overtook them at six months.